Immune-Onc Therapeutics

Immune-Onc Therapeutics

Phase 1
Palo Alto, United StatesFounded 2016immune-onc.com

Immunotherapy, which harnesses the body’s own immune system to fight against disease, has changed the way we think about treatment — and even cures. Recent breakthroughs in our understanding of the role of myeloid cells may yield entirely novel therapies that can further unlock the immune system’s ability to defeat certain cancers and autoimmune diseases.

Founded
2016
Focus
AntibodiesBiologics

About

Immunotherapy, which harnesses the body’s own immune system to fight against disease, has changed the way we think about treatment — and even cures. Recent breakthroughs in our understanding of the role of myeloid cells may yield entirely novel therapies that can further unlock the immune system’s ability to defeat certain cancers and autoimmune diseases.

Funding History

3

Total raised: $50M

Series B Extension$15MVivo CapitalJan 15, 2020
Series B$21MVivo CapitalOct 15, 2018
Series A$14MKleiner PerkinsAug 15, 2016

Company Info

TypePrivate
Founded2016
LocationPalo Alto, United States
StagePhase 1
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile